Develops and validates deprescribing algorithms in chronic kidney disease patients, suggesting improved medication management.
Patients with chronic kidney disease (CKD) are often treated with multiple medications, leading to polypharmacy, which may be inappropriate. Deprescribing has emerged as a proactive intervention to address the risks associated with inappropriate polypharmacy. Evidence-based tools and guidelines are crucial to enhance healthcare providers' ability to deprescribe effectively. While several deprescribing tools and guidelines exist for several populations of patients, their utility in CKD settings remains limited.
No takes yet. Share an insight, caveat, or question.
Hamad et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: